Skip to main content
. 2017 Oct 10;16:126. doi: 10.1186/s12933-017-0609-4

Table 2.

Characteristics, risk factors, and diagnostic and therapeutic procedures for myocardial infarction admissions in type 2 diabetes mellitus (T2DM) versus non-diabetic patients, according to year of study (2002, 2006, 2010, and 2014)

2002 2006 2010 2014
T2DM No T2DM p value T2DM No T2DM p value T2DM No T2DM p value T2DM No T2DM p value
N (%) 12,217 (100) 12,217 (100) NA 13,013 (100) 13,013 (100) NA 12,739 (100) 12,739 (100) NA 12,458 (100) 12,458 (100) NA
Age adjusted rate per 100.000 inhabitantsa 63.69 NA NA 61.97 NA NA 55.86 NA NA 51.07 NA NA
Male sex, n (%)a,b 7757 (63.49) 7757 (63.49) NA 8855 (68.05) 8855 (68.05) NA 8892 (69.8) 8892 (69.8) NA 8819 (70.79) 8819 (70.79) NA
Age, mean (SD)a,b 71.01 (10.73) 71.01 (10.73) NA 70.87 (11.49) 70.87 (11.49) NA 70.5 (12.05) 70.5 (12.05) NA 70.23 (12.36) 70.23 (12.36) NA
40–59 years, n (%) 1965 (16.08) 1965 (16.08) NA 2411 (18.53) 2411 (18.53) NA 2642 (20.74) 2642 (20.74) NA 2775 (22.27) 2775 (22.27) NA
60–69 years, n (%) 2927 (23.96) 2927 (23.96) 2845 (21.86) 2845 (21.86) 2957 (23.21) 2957 (23.21) 3022 (24.26) 3022 (24.26)
70–79 years, n (%) 4559 (37.32) 4559 (37.32) 4448 (34.18) 4448 (34.18) 3764 (29.55) 3764 (29.55) 3217 (25.82) 3217 (25.82)
≥ 80 years, n (%) 2766 (22.64) 2766 (22.64) 3309 (25.43) 3309 (25.43) 3376 (26.5) 3376 (26.5) 3444 (27.64) 3444 (27.64)
CCI, mean (SD)a,b 2.65 (0.82) 1.52 (0.74) < 0.01 2.7 (0.88) 1.56 (0.8) < 0.01 2.76 (0.9) 1.58 (0.82) < 0.01 2.8 (0.92) 1.62 (0.85) < 0.01
Smoking, n (%)a,b 2938 (24.05) 3275 (26.81) < 0.01 4116 (31.63) 4593 (35.3) < 0.01 4566 (35.84) 5258 (41.27) < 0.01 4773 (38.31) 5536 (44.44) < 0.01
Obesity, n (%)a,b 1019 (8.34) 565 (4.62) < 0.01 1488 (11.43) 831 (6.39) < 0.01 1991 (15.63) 1130 (8.87) < 0.01 2238 (17.96) 1275 (10.23) < 0.01
Hypertension, n (%)a,b 6047 (49.5) 4687 (38.36) < 0.01 7511 (57.72) 6038 (46.4) < 0.01 7576 (59.47) 5954 (46.74) < 0.01 7401 (59.41) 5938 (47.66) < 0.01
Lipid metabolism disorders, n (%)a,b 1518 (12.43) 1118 (9.15) < 0.01 2940 (22.59) 2187 (16.81) < 0.01 4794 (37.63) 3592 (28.2) < 0.01 5715 (45.87) 4019 (32.26) < 0.01
Renal diseases, n (%)a,b 974 (7.97) 604 (4.94) < 0.01 1355 (10.41) 853 (6.55) < 0.01 1755 (13.78) 1031 (8.09) < 0.01 2034 (16.33) 1287 (10.33) < 0.01
Atrial fibrillation, n (%)a,b 1445 (11.83) 1574 (12.88) 0.011 1592 (12.23) 1707 (13.12) 0.029 1673 (13.13) 1689 (13.26) 0.760 1779 (14.28) 1800 (14.45) 0.697
CHF, n (%)a 2842 (23.26) 2263 (18.52) < 0.01 3125 (24.01) 2357 (18.11) < 0.01 3175 (24.92) 2307 (18.11) < 0.01 3171 (25.45) 2331 (18.71) < 0.01
Mechanical ventilation, n (%)a 559 (4.58) 504 (4.13) 0.082 519 (3.99) 484 (3.72) 0.259 445 (3.49) 514 (4.03) 0.022 448 (3.6) 446 (3.58) 0.070
HD/DP, n (%)a 83 (0.68) 69 (0.56) 0.257 160 (1.23) 86 (0.66) < 0.01 172 (1.35) 85 (0.67) < 0.01 182 (1.46) 95 (0.76) < 0.01
CABG, n (%) 220 (1.8) 219 (1.79) 0.961 224 (1.72) 210 (1.61) 0.495 246 (1.93) 233 (1.83) 0.547 236 (1.89) 204 (1.64) 0.127
PCI, n (%)a,b 2038 (16.68) 2357 (19.29) < 0.01 4172 (32.06) 4586 (35.24) < 0.01 5677 (44.56) 6097 (47.86) < 0.01 6643 (53.32) 7096 (56.96) < 0.01
Fibrinolysis, n (%)a,b 1613 (13.2) 1694 (13.87) 0.109 1289 (9.91) 1451 (11.15) 0.001 906 (7.11) 1048 (8.23) 0.001 463 (3.72) 567 (4.55) 0.001
LHS, mean (SD)a,b 10.59 (9.14) 10.08 (9.45) < 0.01 9.62 (8.7) 8.82 (8.28) < 0.01 8.47 (9.23) 8.17 (11.51) 0.021 7.58 (7.18) 7.17 (7.86) < 0.01
In-hospital mortality, n (%)a,b 1670 (13.67) 1418 (11.61) < 0.01 1409 (10.83) 1234 (9.48) < 0.01 1209 (9.49) 1097 (8.61) 0.011 991 (7.95) 899 (7.22) 0.022

CCI charlson comorbidity index, CHF congestive heart failure, HD/DP hemodyalisis/peritoneal dialysis, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, LHS length of hospital stay

aSignificant time trend among T2DM sufferers

bSignificant time trend among non-T2DM sufferers